Overview
Kelly Pendergrass is a Hematologist Oncology provider in Lees Summit, Missouri. Dr. Pendergrass is rated as an Experienced provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Hemoglobin SC Disease, Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPN), and Paget Disease of the Breast.
His clinical research consists of co-authoring 7 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Kansas Hospital Authority
Brian Osgood is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Osgood is rated as an Advanced provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Familial Prostate Cancer, Endometrial Cancer, and Desmoplastic Small Round Cell Tumor. Dr. Osgood is currently accepting new patients.
Midwest Oncology Associates LLC
Mohammad Mozayen is a Hematologist Oncology specialist and a Hematologist in Lee's Summit, Missouri. Dr. Mozayen is rated as a Distinguished provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Neuroendocrine Tumor, Lung Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Mozayen is currently accepting new patients.
University Of Kansas Hospital Authority
Christopher Sirridge is a Hematologist Oncology specialist and an Oncologist in Overland Park, Kansas. Dr. Sirridge is rated as a Distinguished provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Congenital Antithrombin 3 Deficiency, Protein C Deficiency, and Protein S Deficiency. Dr. Sirridge is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hemoglobin SC DiseaseDr. Pendergrass isDistinguished. Learn about Hemoglobin SC Disease.
- Myelodysplastic Syndrome (MDS)Dr. Pendergrass isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Breast CancerDr. Pendergrass isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Pendergrass isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Pendergrass isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Follicular LymphomaDr. Pendergrass isAdvanced. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Pendergrass isAdvanced. Learn about Gastric Lymphoma.
- Hemoglobin C DiseaseDr. Pendergrass isAdvanced. Learn about Hemoglobin C Disease.
- Experienced
- Acute Eosinophilic PneumoniaDr. Pendergrass isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Pendergrass isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Pendergrass isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Pendergrass isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Pendergrass isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- ALK-Positive Non-Small Cell Lung CancerDr. Pendergrass isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.